Down 1.8% to $60.88, Isis Pharmaceuticals (NASDAQ:ISIS), is one of today's notable movers. The Dow Jones Industrial Average is now trading 0.5% higher to 17,980 and the S&P is trading fractionally higher to 2,104.
Isis Pharmaceuticals (NASDAQ:ISIS) has potential upside of 12.5% based on a current price of $60.88 and analysts' consensus price target of $68.50. Isis Pharmaceuticals shares should encounter resistance at the 50-day moving average (MA) of $63.94 and support at its 200-day MA of $58.69.
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
Isis Pharmaceuticals share prices have moved between a 52-week high of $77.80 and a 52-week low of $6.25 and are now trading 874% above that low price at $60.88 per share. Over the past week, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has declined 0.3%.